factual
Muscle Trials Hard in Degenerating Elderly Patients
Clinical trials of muscle-targeted drugs in elderly patients with age-related weakness are very difficult because decline is steep, making moderate effects hard to detect, and the same challenge affects Alzheimer's trials.
factualpending
Speaker
Dinakar SinghEvidence Quote
“clinical trials, and this is the problem with Alzheimer's, are very, very challenging in elderly, degenerating patients”
Source
Dinakar Singh - A Father’s Call To Action - [Invest Like the Best, EP.428]— Invest Like the BestCreated: 11/12/2026, 3:19:03 AM
Your notes
Loading notes...